Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1728.7519.85 (+1.16 %)

PREV CLOSE ( ) 1708.90

OPEN PRICE ( ) 1708.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4875

TODAY'S LOW / HIGH ( )1680.05 1794.40

52 WK LOW / HIGH ( )1200 2130

NSE1724.1013.6 (+0.8 %)

PREV CLOSE( ) 1710.50

OPEN PRICE ( ) 1700.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1724.10 (504)

VOLUME 90957

TODAY'S LOW / HIGH( ) 1680.10 1790.00

52 WK LOW / HIGH ( )1277.8 2131

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

16953.63

14868.75

15056.22

14249.09

Total Expenditure

12604.87

11729.89

11378.6

10773.94

PBIDT (Excl OI)

4348.76

3138.86

3677.62

3475.15

Other Income

631.73

841.62

575.27

440.29

Operating Profit

4980.49

3980.48

4252.89

3915.44

Interest

39.3

78.23

114.96

74.5

Exceptional Items

-243.46

PBDT

4697.73

3902.25

4137.93

3840.94

Depreciation

1076.45

1063.1

1010.52

957.61

Profit Before Tax

3621.28

2839.15

3127.41

2883.33

Tax

1006.53

1002.31

972.59

1017.92

Provisions and contingencies

Profit After Tax

2614.75

1836.84

2154.82

1865.41

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2614.75

1836.84

2154.82

1865.41

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2614.75

1836.84

2154.82

1865.41

Equity Capital

164.76

Face Value (IN RS)

Reserves

Calculated EPS

15.87

11.14

13.07

11.32

Calculated EPS (Annualised)

63.48

44.59

52.31

45.28

No of Public Share Holdings

79362489

% of Public Share Holdings

48.17

PBIDTM% (Excl OI)

25.65

21.11

24.42

24.38

PBIDTM%

29.37

26.77

28.24

27.47

PBDTM%

27.70

26.24

27.48

26.95

PBTM%

21.35

19.09

20.77

20.23

PATM%

15.42

12.35

14.31

13.09

Notes

Risk Disclosures on Derivatives

Quarterly Results

GLAND PHARMA LTD.